Likewise, IL-8 was reported to induce stemness and EGFR inhibitor resistance in lung cancer [93], and CXCR1/2 inhibition decreased tumor growth, metastasis, and angiogenesis of lung cancer xenografts [94]. This evidence concerns the gene CXCR1 and lung carcinoma.